Literature DB >> 8609493

Expression of bacteriophage T7 RNA polymerase in avian and mammalian cells by a recombinant fowlpox virus.

P Britton1, P Green, S Kottier, K L Mawditt, Z Penzes, D Cavanagh, M A Skinner.   

Abstract

The bacteriophage T7 RNA polymerase gene was integrated into the fowlpox virus genome under the control of the vaccinia virus early/late promoter, P7.5. The recombinant fowlpox virus, fpEFLT7pol, stably expressed T7 RNA polymerase in avian and mammalian cells, allowing transient expression of transfected genes under the control of the T7 promoter. The recombinant fowlpox virus expressing T7 RNA polymerase offers an alternative to the widely used vaccinia virus vTF7-3, or the recently developed modified vaccinia virus Ankara (MVA) T7 RNA polymerase recombinant, a highly attenuated strain with restricted host-range. Recombinant fowlpox viruses have the advantage that as no infectious virus are produced from mammalian cells they do not have to be used under stringent microbiological safety conditions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609493     DOI: 10.1099/0022-1317-77-5-963

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  33 in total

1.  Creation of a nonspreading Rift Valley fever virus.

Authors:  Jeroen Kortekaas; Nadia Oreshkova; Viviana Cobos-Jiménez; Rianka P M Vloet; Christiaan A Potgieter; Rob J M Moormann
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Reverse genetics system for the avian coronavirus infectious bronchitis virus.

Authors:  R Casais; V Thiel; S G Siddell; D Cavanagh; P Britton
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Gene 5 of the avian coronavirus infectious bronchitis virus is not essential for replication.

Authors:  Rosa Casais; Marc Davies; David Cavanagh; Paul Britton
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Infectious bursal disease virus capsid protein VP3 interacts both with VP1, the RNA-dependent RNA polymerase, and with viral double-stranded RNA.

Authors:  Mirriam G J Tacken; Ben P H Peeters; Adri A M Thomas; Peter J M Rottier; Hein J Boot
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  Murine norovirus: propagation, quantification, and genetic manipulation.

Authors:  Seungmin Hwang; Bader Alhatlani; Armando Arias; Sarah L Caddy; Constantina Christodoulou; Juliana Bragazza Cunha; Ed Emmott; Marta Gonzalez-Hernandez; Abimbola Kolawole; Jia Lu; Christine Rippinger; Frédéric Sorgeloos; Lucy Thorne; Surender Vashist; Ian Goodfellow; Christiane E Wobus
Journal:  Curr Protoc Microbiol       Date:  2014-05-01

6.  Recombinant canine distemper virus strain Snyder Hill expressing green or red fluorescent proteins causes meningoencephalitis in the ferret.

Authors:  M Ludlow; D T Nguyen; D Silin; O Lyubomska; R D de Vries; V von Messling; S McQuaid; R L De Swart; W P Duprex
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

7.  Exchange of the C-terminal part of VP3 from very virulent infectious bursal disease virus results in an attenuated virus with a unique antigenic structure.

Authors:  Hein J Boot; A Agnes H M ter Huurne; Arjan J W Hoekman; Jan M Pol; Arno L J Gielkens; Ben P H Peeters
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  Transient Dominant Selection for the Modification and Generation of Recombinant Infectious Bronchitis Coronaviruses.

Authors:  Sarah Keep; Paul Britton; Erica Bickerton
Journal:  Methods Mol Biol       Date:  2020

9.  Recovery of genetically defined murine norovirus in tissue culture by using a fowlpox virus expressing T7 RNA polymerase.

Authors:  Yasmin Chaudhry; Michael A Skinner; Ian G Goodfellow
Journal:  J Gen Virol       Date:  2007-08       Impact factor: 3.891

10.  The replicase gene of avian coronavirus infectious bronchitis virus is a determinant of pathogenicity.

Authors:  Maria Armesto; Dave Cavanagh; Paul Britton
Journal:  PLoS One       Date:  2009-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.